A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo

被引:45
作者
McKesey, Jacqueline [1 ]
Pandya, Amit G. [1 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Dermatol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
关键词
D O I
10.1016/j.jaad.2019.04.032
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:646 / 648
页数:4
相关论文
共 5 条
[1]  
[Anonymous], XELJANZ PRICES COUPO
[2]  
Ciechanowicz P, 2018, J DERMATOL TREAT, P1
[3]   Parametric modeling of UV-B of narrowband phototherapy for vitiligo using a novel quantitative tool - The vitiligo area scoring index [J].
Hamzavi, I ;
Jain, H ;
McLean, D ;
Shapiro, J ;
Zeng, HS ;
Lui, H .
ARCHIVES OF DERMATOLOGY, 2004, 140 (06) :677-683
[4]   The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo [J].
Mohammad, Tasneem F. ;
Al-Jamal, Mohammed ;
Hamzavi, Iltefat H. ;
Harris, John E. ;
Leone, Giovanni ;
Cabrera, Raul ;
Lim, Henry W. ;
Pandya, Amit G. ;
Esmat, Samia M. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (05) :879-888
[5]   Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib [J].
Rothstein, Brooke ;
Joshipura, Deep ;
Saraiya, Ami ;
Abdat, Rana ;
Ashkar, Huda ;
Turkowski, Yana ;
Sheth, Vaneeta ;
Huang, Victor ;
Au, Shiu Chung ;
Kachuk, Courtney ;
Dumont, Nicole ;
Gottlieb, Alice B. ;
Rosmarin, David .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) :1054-+